Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M147,784Revenue (TTM) $M16,380Net Margin (%)31.3Altman Z-Score16.6
Enterprise Value $M144,786EPS (TTM) $2.0Operating Margin %43.6Piotroski F-Score7
P/E(ttm)28.6Beneish M-Score-2.4Pre-tax Margin (%)39.1Higher ROA y-yN
Price/Book26.710-y EBITDA Growth Rate %19.2Quick Ratio0.8Cash flow > EarningsY
Price/Sales9.05-y EBITDA Growth Rate %18.8Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow28.3y-y EBITDA Growth Rate %5.1ROA % (ttm)41.2Higher Current Ratio y-yY
Dividend Yield %1.7PEG1.5ROE % (ttm)86.7Less Shares Outstanding y-yY
Payout Ratio %47.0Shares Outstanding M2,600ROIC % (ttm)141Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVOKen Fisher 2016-03-31 Reduce-0.03%$46.58 - $58.08
($53.57)
$ 56.546%Reduce -2.35%11,178,809
NVORuane Cunniff 2016-03-31 Add0.01%$46.58 - $58.08
($53.57)
$ 56.546%Add 19.93%97,525
NVOMario Gabelli 2016-03-31 Add$46.58 - $58.08
($53.57)
$ 56.546%Add 0.24%6,225
NVOKen Fisher 2015-12-31 Reduce-0.02%$52.93 - $58.77
($55.36)
$ 56.542%Reduce -1.76%11,447,413
NVOMario Gabelli 2015-12-31 Add$52.93 - $58.77
($55.38)
$ 56.542%Add 0.65%6,210
NVOKen Fisher 2015-09-30 Reduce-0.07%$52.8 - $60.23
($56.62)
$ 56.54-0%Reduce -5.23%11,652,268
NVORuane Cunniff 2015-09-30 Reduce$52.8 - $60.23
($56.62)
$ 56.54-0%Reduce -0.59%81,320
NVOMario Gabelli 2015-09-30 Reduce$52.8 - $60.23
($56.62)
$ 56.54-0%Reduce -5.73%6,170
NVOKen Fisher 2015-06-30 Reduce-0.04%$53.39 - $58.02
($56.17)
$ 56.541%Reduce -2.88%12,295,864
NVOMario Gabelli 2015-06-30 Reduce$53.39 - $58.02
($56.17)
$ 56.541%Reduce -2.31%6,545
NVORuane Cunniff 2015-06-30 Reduce$53.39 - $58.02
($56.17)
$ 56.541%Reduce -0.30%81,800
NVOKen Fisher 2015-03-31 Reduce-0.03%$41.9 - $54.68
($46.05)
$ 56.5423%Reduce -2.91%12,660,235
NVORuane Cunniff 2015-03-31 Reduce$41.9 - $54.68
($46.05)
$ 56.5423%Reduce -0.17%82,050
NVOMario Gabelli 2015-03-31 Reduce$41.9 - $54.68
($46.05)
$ 56.5423%Reduce -0.30%6,700
NVORuane Cunniff 2014-09-30 Reduce-0.02%$43.9 - $49.03
($46)
$ 56.5423%Reduce -52.87%75,642
NVORuane Cunniff 2014-06-30 Reduce-0.02%$42.28 - $46.52
($44.12)
$ 56.5428%Reduce -33.85%160,492
NVORuane Cunniff 2014-03-31 Reduce-0.01%$36.722 - $48.23
($42.37)
$ 56.5433%Reduce -21.98%242,630
NVORuane Cunniff 2013-12-31 Add0.02%$32.72 - $36.95
($34.88)
$ 56.5462%Add 58.71%310,970
NVOTom Gayner 2013-12-31 Reduce$32.72 - $36.95
($34.88)
$ 56.5462%Reduce -0.23%1,106,000
NVOKen Fisher 2013-12-31 Add$32.72 - $36.95
($34.88)
$ 56.5462%Add 0.29%13,553,935
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about NVO:

    News about NVO:

    Articles On GuruFocus.com
    My Favorite Health Care Stocks Jul 12 2016 
    Nintai Charitable Trust's 2nd-Quarter Results Jul 01 2016 
    High Yield, Strong Returns: Sturm Ruger, Nu Skin Enterprises Jun 23 2016 
    Stocks Mario Gabelli Has Bought for 2 Quarters Jun 20 2016 
    Jim Simons' Top Holdings Include VeriSign, Chipotle Dec 15 2015 
    Value Investing in BioPharma Nov 18 2015 
    Jim Simons' Five Most-Heavily Weighted Holdings Oct 21 2015 
    Ken Fisher Reduces Stake in Toyota, Increases Position in Anheuser-Busch Oct 20 2015 
    Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S Sep 14 2015 
    Nintai Returns: Q2 2015 Jul 01 2015 

    More From Other Websites
    European shares propped up by healthcare and consumer stocks Jul 26 2016
    European shares propped up by healthcare and consumer stocks Jul 26 2016
    Novo Nordisk A/S - Share repurchase programme Jul 25 2016
    Eli Lilly, J&J, Novo Battle Diabetes -- And Each Other Jul 22 2016
    Novo Nordisk A/S - Share repurchase programme Jul 18 2016
    The CHMP Just Recommended the Extension of These Drugs’ Therapeutic Indications Jul 12 2016
    My Favorite Health Care Stocks Jul 12 2016
    Novo Nordisk to present 28 abstracts at the World Federation of Hemophilia Congress Jul 12 2016
    Novo Nordisk A/S - Share repurchase programme Jul 11 2016
    Novo Nordisk invests DKK 400 million in an expanded production plant in Kalundborg Jul 04 2016
    Status vedrørende Novo Nordisks beholdning af egne aktier (30. juni 2016) Jul 04 2016
    Status regarding Novo Nordisk's holding of its own shares (30 June 2016) Jul 01 2016
    Novo Nordisk A/S - Share repurchase programme Jul 01 2016
    Why Are Novo Nordisk’s Two Segments Growing? Jun 30 2016
    What Are Analysts Thinking about Novo Nordisk? Jun 30 2016
    Why Market Share for Novo Nordisk’s Tresiba Is Set to Grow Jun 29 2016
    Could Novo Nordisk’s 2016 Earnings Impress Wall Street? Jun 28 2016
    Novo Nordisk A/S - aktietilbagekøbsprogram Jun 28 2016
    EMA grants marketing authorisation of mylife(TM) YpsoPump® for use with NovoRapid® PumpCart®,... Jun 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)